Fish: A Promising Screening Tool for Malignancy After Augmentation Cystoplasty?

In brief

This study evaluates fluorescence in situ hybridization (FISH) as a non-invasive screening method for detecting bladder malignancy in patients who have undergone augmentation cystoplasty, a population with elevated cancer risk up to 5.5%. The research addresses the need for effective surveillance strategies in this high-risk patient group.

Written by the GCMD Library team from the article.